Amerikanische Gesellschaft für Hirudotherapie

Gut microbiota and metabolic function in leeches with distinct feeding niches

Microbiology article published in BMC Microbiology (2026)

Zuletzt aktualisiert: June 18, 2026Geprüft von: ASH Editorial Board
Research article — evidence reviewArticle reference
Evidence: Research reportGenomik & ProteomikSicherheit & InfektionskontrolleTong X, Yang D, Cao X et al. · BMC microbiology, 2026

Abstract

BACKGROUND: The gut microbiota has co-evolved with its host and plays a vital role in maintaining physiological homeostasis and health. Understanding the composition of microbial communities in leech guts may reveal important insights into their ecological adaptations and feeding strategies. OBJECTIVE: This study aimed to compare the gut microbiota of hematophagous (blood-feeding) and non-hematophagous leeches, to identify microbial signatures associated with dietary divergence and niche specialization. METHODS: Gut contents were collected from representative species of hematophagous and non-hematophagous leeches. The microbial community composition was analyzed via 16 S rRNA gene sequencing. RESULTS: A total of 751 microbial species were identified, encompassing 535 genera, 332 families, 203 orders, 86 classes, and 39 phyla. At the phylum level, Proteobacteria and Firmicutes were significantly more abundant in hematophagous leeches than in non-hematophagous leeches, whereas Bacteroidetes predominated in non-hematophagous counterparts. At the genus level, hematophagous leeches exhibited higher abundances of Elstera, unclassified genus of Rhodospirillaceae, Aeromonas, unclassified genus of Rhodospirillales, unclassified genus of Peptostreptococcales-Tissierellales, and unclassified genus of Oscillospirales. In contrast, unclassified genus of Comamonadaceae, Nubsella, Cetobacterium, Mucispirillum, unclassified genus of Peptostreptococcaceae, and Bacteroides were enriched in non-hematophagous leeches. Functional prediction analysis revealed significant differences in five key metabolic pathways between the two groups: lipid transport and metabolism, amino acid transport and metabolism, nucleotide transport and metabolism, translation and ribosomal structure biogenesis, and coenzyme transport and metabolism. CONCLUSION: Distinct taxonomic and functional profiles characterize the gut microbiota of hematophagous and non-hematophagous leeches. These results provide microbiological evidence for dietary specialization in leeches and offer a basis for guiding domestication and artificial breeding strategies.

Abstract sourced from PubMed (NCBI) for the cited record. See the original publication for the authoritative version.

Publication typeJournal Article

Zusammenfassung

Comparative gut-microbiota profiling across leech species with distinct feeding niches reveals diet-dependent microbial community structure and metabolic capability, expanding the understanding of leech holobiont ecology.

Warum dies für die Hirudotherapie relevant ist

This study compared gut microbiota of hematophagous and non-hematophagous leeches using 16S rRNA gene sequencing of gut contents, identifying 751 microbial species and distinct taxonomic and functional profiles, with Proteobacteria and Firmicutes enriched in blood-feeding leeches and Bacteroidetes in non-blood-feeders. Functional prediction highlighted differences in lipid, amino acid, nucleotide, coenzyme, and translation-related metabolic pathways. The abstract's stated focus is on ecology, dietary specialization, and breeding strategies, with no mention of medicinal use, hirudotherapy, or clinical applications. For ASH, the relevance to hirudotherapy is not established by this abstract; the study provides ecological and microbiological data on leech gut communities, not therapeutic outcomes.

Zitation

Gut microbiota and metabolic function in leeches with distinct feeding niches.

Tong X, Yang D, Cao X et al. · BMC microbiology, 2026

Verwandter klinischer Kontext

Zur ASH-Bibliothek hinzugefügt: May 26, 2026 · Letzte Aktualisierung der Website: June 18, 2026

Diese Website stellt Bildungsinformationen bereit und ist weder eine medizinische Beratung noch eine Diagnose oder Behandlungsempfehlung. Die medizinische Blutegeltherapie ist mit klinisch relevanten Risiken verbunden und sollte ausschließlich von qualifizierten Klinikerinnen und Klinikern unter institutionell genehmigten Protokollen durchgeführt werden. Die FDA-510(k)-Zulassung für medizinische Blutegel ist auf bestimmte Indikationen beschränkt; experimentelle und Off-Label-Diskussionen werden entsprechend gekennzeichnet. Für patientenspezifische Beratung wenden Sie sich an eine qualifizierte Gesundheitsfachkraft.